ATOS Key Stats
- Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annu... May 23
- Nasdaq stocks posting largest percentage decreases May 22
- Atossa Genetics to Sponsor Screenings of Decoding Annie Parker at the Seattle In... May 21
- Atossa Genetics to Present at the Sidoti Semi-Annual Microcap Conference Marketwired May 20
- May 2013 IPO Market Update May 19
- Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference PR Newswire May 17
- Atossa Gntcs (ATOS) Posts Q1 Loss of 14c/Share Street Insider May 15
- Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights Marketwired May 15
- ATOSSA GENETICS INC Files SEC form 10-Q, Quarterly Report May 15
- Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum a... May 14
ATOS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Atossa Genetics is down 0.58% over the last year vs S&P 500 Total Return up 27.96%, Meridian Bioscience up 19.07%, and Abaxis up 37.58%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for ATOS
Pro Report PDF for ATOS
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ATOS Pro Report PDF
Pro Strategies Featuring ATOS
Did Atossa Genetics make it into our Pro Portfolio Strategies?